TKPHF TAKEDA PHARMACEUTICAL CO LTD
- 24.870
- -0.510-2.01%
TAKEDA PHARMACEUTICAL CO LTD News
6-K: Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
6-K: Semi-annual Securities Report
6-K: Earnings Report for the Six-month Period Ended September 30, 2024
6-K: Notice of the Revised Forecast of Consolidated Financials for FY2024
6-K: Earnings Report for the Three-month Period Ended June 30, 2024
6-K: Corporate Governance Report
6-K: 2024 Annual Integrated Report
20-F: FY2024 Annual Report
6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
No Data